Liu GY, Ye YF, Jiang YF, Chen GJ, et al. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ 2024;385:e077890.
PMID: 38897625